SINOVAC BIOTECH LTD (SVA) Executive Compensation
SINOVAC BIOTECH LTD (SVA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SVA
CIK: 1084201
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: B9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Zhonghua Certified Public Accountants LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerFang Li
Audit LocationShanghai, China
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-08-17 | 2026-08-17 | 6-K | 0001193125-26-353263 | View SEC Doc Filr Page |
| 6-K | 2026-07-15 | 2026-07-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-078116 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-068483 | View SEC Doc Filr Page |
| 6-K | 2026-06-05 | 2026-06-05 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-065846 | View SEC Doc Filr Page |
| 20-F | 2026-06-05 | 2025-12-31 | 20-F | 0001193125-26-258534 | View SEC Doc Filr Page |
| 6-K | 2026-05-29 | 2026-05-29 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-062907 | View SEC Doc Filr Page |
| 6-K | 2026-05-21 | 2026-05-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-059828 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2026-05-08 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-054027 | View SEC Doc Filr Page |
| 6-K | 2026-05-07 | 2026-05-07 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-053039 | View SEC Doc Filr Page |
| NT 20-F | 2026-04-30 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-049775 | View SEC Doc Filr Page |
| 20-F | 2026-04-30 | 2024-12-31 | 20-F | 0001193125-26-194394 | View SEC Doc Filr Page |
| 3 | 2026-04-17 | 2026-04-17 | 3 Filing | 0001213900-26-044883 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029904 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029894 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029885 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029883 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029866 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029856 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029850 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029840 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029807 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029801 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029794 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-029784 | View SEC Doc Filr Page |
| 6-K | 2026-01-22 | 2026-01-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-006442 | View SEC Doc Filr Page |